Solaxa

Developer of therapeutics for rare neurodegenerative disease and acute nerve injuries

placeBethesda, Maryland, United States calendar_todayFounded 2021 language solaxa.com

Registered entities

Social engagement

Social engagement: 719 social following, 3 posts in the last 12 months — top 10% of its industry.

Investor mix

1 investor on record; lead investors include TEDCO.

Investor typeCountShare
Venture capital1100%
Coming soon